Literature DB >> 37707

Elevated serum uric acid levels during treatment with antihypertensive drugs.

C Bengtsson.   

Abstract

An increase in serum uric acid levels has been observed both during treatment with diuretics and beta-blockers. The increase during treatment with beta-blockers seems in most cases to be of no clinical importance and is not a reason for serum uric acid determinations of subjects who have no symptoms indicating hyperuricaemia. During treatment with diuretics in those doses which have been commonly used previously, e.g. hydrochlorothiazide or chlorthalidone greater than or equal to 50 mg/d, an increase on an average of about 90 mumol/l is to be expected. When low-dose diuretics are used (e.g. hydrochlorothiazide or chlorthalidone less than or equal to 25 mg/d) about half of this increase might be anticipated. It is recommended that serum uric acid levels should be studied after starting antihypertensive treatment with diuretics.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 37707     DOI: 10.1111/j.0954-6820.1979.tb00781.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  6 in total

Review 1.  Serum uric acid is not an independent risk factor for coronary heart disease.

Authors:  S G Wannamethee
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Serum potassium and cardiovascular mortality.

Authors:  J Fang; S Madhavan; H Cohen; M H Alderman
Journal:  J Gen Intern Med       Date:  2000-12       Impact factor: 5.128

3.  Determinants of serum uric acid levels in an adult general population: results from the Moli-sani Study.

Authors:  Sara Magnacca; Simona Costanzo; Amalia De Curtis; Augusto Di Castelnuovo; Marco Olivieri; Chiara Cerletti; Giovanni de Gaetano; Maria Benedetta Donati; Licia Iacoviello
Journal:  Clin Rheumatol       Date:  2020-07-16       Impact factor: 2.980

4.  Epidemiology of hyperuricemia in the elderly.

Authors:  S W Lai; C K Tan; K C Ng
Journal:  Yale J Biol Med       Date:  2001 May-Jun

5.  Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country.

Authors:  D Conen; V Wietlisbach; P Bovet; C Shamlaye; W Riesen; F Paccaud; M Burnier
Journal:  BMC Public Health       Date:  2004-03-25       Impact factor: 3.295

6.  Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.

Authors:  Damian J Damian; Roseanne McNamee; Matthew Carr
Journal:  BMC Cardiovasc Disord       Date:  2016-10-04       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.